total assets (39,364): $1,090.91T
real estate: $450.36T
commodities (7): $232.78T
companies (20,810): $147.11T
currencies (113): $139.67T
govt bonds (177): $118.17T
cryptos (12,661): $2.82T
Advertise
Sign up

Get the App

Scan with your phone to download. 35,000+ assets in your pocket.

Google Play QR code Google Play
App Store

The global leaderboard of wealth: $1.2 Quadrillion of Assets ranked by Market Cap

Companies

NervGen Pharma Corp. (NGEN) Discusses Challenges and Advances in Drug and Therapy Trials for Spinal Cord Injury Transcript

By seekingalpha.com · · 1 min read
NervGen Pharma Corp. (NGEN) Discusses Challenges and Advances in Drug and Therapy Trials for Spinal Cord Injury Transcript

NervGen Pharma Corp. (NGEN) Discusses Challenges and Advances in Drug and Therapy Trials for Spinal Cord Injury Transcript

Read the full article on seekingalpha.com

Comments 0

No comments yet. Be the first to share your thoughts!

← All News articles
—— As Seen On ——